Skip to main content
Top
Published in: CEN Case Reports 2/2020

01-05-2020 | Case Report

Unusual manifestation of monoclonal gammopathy of undetermined significance: a false serum creatinine elevation

Authors: Yoshinosuke Shimamura, Takuto Maeda, Yayoi Ogawa, Yuki Nagai, Toshiya Shinohara, Hideki Takizawa

Published in: CEN Case Reports | Issue 2/2020

Login to get access

Abstract

A 72-year-old Japanese man with diabetes mellitus and hypertension presented with an acutely elevated serum creatinine level, from 1.02 to 4.13 mg/dL over 2 months as measured by the enzymatic method by pure-auto S CRE-N®. Renal biopsy could not identify the etiology of the elevating sCr. However, an elevated total protein level (8.2 g/dL) and lowering of the BUN and sCr ratio from 14.5 to 2.7 were found, and bone marrow biopsy showed less than 10% lymphoplasmacytic infiltration, compatible with monoclonal gammopathy of undetermined significance. The diagnosis of a false serum creatinine elevation due to monoclonal gammopathy of undetermined significance was confirmed with the serum cystatin C level at 1.05 mg/dL and the creatinine level of 0.97 mg/dL using Shikarikid-S CRE® method. Although cases of monoclonal gammopathy of undetermined significance with a false serum creatinine elevation as an initial presentation are rare, this condition should be considered in patients with paraproteinemia; measuring the renal function using cystatin C is important in such patients.
Literature
1.
go back to reference Kyle RA. Monoclonal gammopathy of undetermined significance: natural history in 241 cases. Am J Med. 1987;64:814–26.CrossRef Kyle RA. Monoclonal gammopathy of undetermined significance: natural history in 241 cases. Am J Med. 1987;64:814–26.CrossRef
2.
go back to reference Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ III. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004;79:859–66.CrossRef Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ III. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004;79:859–66.CrossRef
3.
go back to reference Kyle RA, Larson DR, Therneau TM, Despenzieri A, Kumar S, Cerhan JR. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378:241–9.CrossRef Kyle RA, Larson DR, Therneau TM, Despenzieri A, Kumar S, Cerhan JR. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378:241–9.CrossRef
4.
go back to reference Rajkumar SV. Plasma cell disorders. In: Goldman L, Schafer AI, editors. Goldman-Cecil Medicine. 25th ed. Philadelphia: Elsevier Saunders; 2016. p. 1273–1284. Rajkumar SV. Plasma cell disorders. In: Goldman L, Schafer AI, editors. Goldman-Cecil Medicine. 25th ed. Philadelphia: Elsevier Saunders; 2016. p. 1273–1284.
5.
go back to reference Berth M, Delanghe J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin Belg. 2004;59:263–73.CrossRef Berth M, Delanghe J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin Belg. 2004;59:263–73.CrossRef
8.
go back to reference Smogorzewska A, Flood JG, Long WH, Dighe AS. Paraprotein interference in automated chemistry analyzers. Clin Chem. 2004;50:1691–3.CrossRef Smogorzewska A, Flood JG, Long WH, Dighe AS. Paraprotein interference in automated chemistry analyzers. Clin Chem. 2004;50:1691–3.CrossRef
9.
go back to reference Tsai LY, Tsai SM, Lee SC, Liu SF. Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein. Clin Chem Acta. 2005;358:192–5.CrossRef Tsai LY, Tsai SM, Lee SC, Liu SF. Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein. Clin Chem Acta. 2005;358:192–5.CrossRef
10.
go back to reference Pantanowitz L, Horowitz GL, Upalakalin JN, Beckwith BA. Artifactual hyperbilirubinemia due to paraprotein interference. Arch Pathol Lab. 2003;127:55–9. Pantanowitz L, Horowitz GL, Upalakalin JN, Beckwith BA. Artifactual hyperbilirubinemia due to paraprotein interference. Arch Pathol Lab. 2003;127:55–9.
11.
go back to reference Murali MR, Kratz A, Finberg KE. Case records of the Massachusetts General Hospital. Case 40–2006. A 64-year-old man with anemia and a low level of HDL cholesterol. N Engl J Med. 2006;355:2772–9.CrossRef Murali MR, Kratz A, Finberg KE. Case records of the Massachusetts General Hospital. Case 40–2006. A 64-year-old man with anemia and a low level of HDL cholesterol. N Engl J Med. 2006;355:2772–9.CrossRef
12.
go back to reference Alyanakian MA, Taes Y, Bensaïd M, Segovia B, Aucouturier P, Rain JD, et al. Monoclonal immunoglobulin with antitransferrin activity: a rare cause of hypersideremia with increased transferrin saturation. Blood. 2007;109:359–61.CrossRef Alyanakian MA, Taes Y, Bensaïd M, Segovia B, Aucouturier P, Rain JD, et al. Monoclonal immunoglobulin with antitransferrin activity: a rare cause of hypersideremia with increased transferrin saturation. Blood. 2007;109:359–61.CrossRef
13.
go back to reference Krish P, Jhaveri KD. Hyperbicarbonatemia in a patient with Waldenstrom's macroglobulinemia Pseudohyperbicarbonatemia due to paraproteinemia. Kidney Int. 2012;81:603–5.CrossRef Krish P, Jhaveri KD. Hyperbicarbonatemia in a patient with Waldenstrom's macroglobulinemia Pseudohyperbicarbonatemia due to paraproteinemia. Kidney Int. 2012;81:603–5.CrossRef
14.
go back to reference Yang Y, Howanitz PJ, Howanitz JH, Gorfajn H, Wong K. Paraproteins are a common cause of interferences with automated chemistry methods. Arch Pathol Lab Med. 2008;132:217–23.PubMed Yang Y, Howanitz PJ, Howanitz JH, Gorfajn H, Wong K. Paraproteins are a common cause of interferences with automated chemistry methods. Arch Pathol Lab Med. 2008;132:217–23.PubMed
15.
go back to reference Miyoshi M, Nishioka M, Hata M, Nakao T, Doi T. Comparative study of measurement error for creatinine concentration in serum six reagents. Jpn J Med Tech. 2017;66:547–53 (in Japanese). Miyoshi M, Nishioka M, Hata M, Nakao T, Doi T. Comparative study of measurement error for creatinine concentration in serum six reagents. Jpn J Med Tech. 2017;66:547–53 (in Japanese).
16.
go back to reference Yamaki M. A case of pseudohypercreatinemia in a patient suffering from macroglobulinemia. Jpn J Nephrol. 2004;46:43–8 (in Japanese). Yamaki M. A case of pseudohypercreatinemia in a patient suffering from macroglobulinemia. Jpn J Nephrol. 2004;46:43–8 (in Japanese).
17.
go back to reference Storsley L, Fine A, Krahn J. IgM monoclonal protein presenting as pseudohypercreatinaemia. Nephrol Dial Transplant. 2006;21:3337–8.CrossRef Storsley L, Fine A, Krahn J. IgM monoclonal protein presenting as pseudohypercreatinaemia. Nephrol Dial Transplant. 2006;21:3337–8.CrossRef
18.
go back to reference Ikeda M, Tsukamoto T, Miyake T, Kakita H, Komiya T, Yonemoto S, et al. A case of pseudohypercreatinemia associated with monoclonal IgM gammopathy. Jpn J Nephrol. 2013;55:1340–4 (in Japanese). Ikeda M, Tsukamoto T, Miyake T, Kakita H, Komiya T, Yonemoto S, et al. A case of pseudohypercreatinemia associated with monoclonal IgM gammopathy. Jpn J Nephrol. 2013;55:1340–4 (in Japanese).
19.
go back to reference Kadatz MJ, Lee ES, Duncan J, Levin A, Johnson O. A peculiar case of Paraproteinemia and elevated creatinine. Am J Kidney Dis. 2018;71:xiv–xv.CrossRef Kadatz MJ, Lee ES, Duncan J, Levin A, Johnson O. A peculiar case of Paraproteinemia and elevated creatinine. Am J Kidney Dis. 2018;71:xiv–xv.CrossRef
20.
go back to reference Hummel KM, von Ahsen N, Kühn RB, Grunewald RW, Oellerich M, Müller GA. Pseudohypercreatiniemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström’s macroglobulinemia. Nephron. 2000;86:188–9.CrossRef Hummel KM, von Ahsen N, Kühn RB, Grunewald RW, Oellerich M, Müller GA. Pseudohypercreatiniemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström’s macroglobulinemia. Nephron. 2000;86:188–9.CrossRef
21.
go back to reference Rudofsky G, Villalobos M, Waldherr R, Schair M, Zorn M, Maimer A, et al. Renal failure in a male with Waldenström’s macroglobulinemia. Kidney Int. 2010;77:371–2.CrossRef Rudofsky G, Villalobos M, Waldherr R, Schair M, Zorn M, Maimer A, et al. Renal failure in a male with Waldenström’s macroglobulinemia. Kidney Int. 2010;77:371–2.CrossRef
22.
go back to reference Kwok J, Chow KM, Lit L, Chan M. Paraproteinemia-associated pseudohypercreatinemia across different analytical methodologies. Kidney Int. 2010;78:621.CrossRef Kwok J, Chow KM, Lit L, Chan M. Paraproteinemia-associated pseudohypercreatinemia across different analytical methodologies. Kidney Int. 2010;78:621.CrossRef
23.
go back to reference Sheppard CR, Allen RC, Austin GE, Young AN, Ribeiro MA, Fantz CR. Paraprotein interference in automated chemistry analyzers. Clin Chem. 2005;51:1077–8.CrossRef Sheppard CR, Allen RC, Austin GE, Young AN, Ribeiro MA, Fantz CR. Paraprotein interference in automated chemistry analyzers. Clin Chem. 2005;51:1077–8.CrossRef
24.
go back to reference Reed RG. Interference by an IgM paraprotein in the bromcresol green method for determination of serum albumin. Clin Chem. 1987;33:1075–6.CrossRef Reed RG. Interference by an IgM paraprotein in the bromcresol green method for determination of serum albumin. Clin Chem. 1987;33:1075–6.CrossRef
25.
go back to reference Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34.CrossRef Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34.CrossRef
26.
go back to reference Ferguson MA, Waiker SS. Established and emerging markers of kidney function. Clin Chem. 2012;58:680–9.CrossRef Ferguson MA, Waiker SS. Established and emerging markers of kidney function. Clin Chem. 2012;58:680–9.CrossRef
27.
go back to reference Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem. 1998;44:1535–9.CrossRef Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem. 1998;44:1535–9.CrossRef
28.
go back to reference Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstöm V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921–6.CrossRef Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstöm V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921–6.CrossRef
29.
go back to reference Mussap M, Ruzzante N, Varagnolo M, Plebani M. Quantitative automated particle-enhanced immunonephelometric assay for the routine measurement of human cystatin C. Clin Chem Lab Med. 1998;36:859–65.CrossRef Mussap M, Ruzzante N, Varagnolo M, Plebani M. Quantitative automated particle-enhanced immunonephelometric assay for the routine measurement of human cystatin C. Clin Chem Lab Med. 1998;36:859–65.CrossRef
30.
go back to reference Tanaka M, Matsuo K, Enomoto M, Mizuno K. A sol particle homogenous immunoassay for measuring serum cystatin C. Clin Biochem. 2004;37:27–35.CrossRef Tanaka M, Matsuo K, Enomoto M, Mizuno K. A sol particle homogenous immunoassay for measuring serum cystatin C. Clin Biochem. 2004;37:27–35.CrossRef
31.
go back to reference Tanaka H, Sakuma Y, Ikeda H, Shimizu R, Sugita Y, Iwai R. Characteristics and prognosis of patients with immunoglobulin M monoclonal gammopathy. J Clin Exp Hematop. 2017;57:47–53.CrossRef Tanaka H, Sakuma Y, Ikeda H, Shimizu R, Sugita Y, Iwai R. Characteristics and prognosis of patients with immunoglobulin M monoclonal gammopathy. J Clin Exp Hematop. 2017;57:47–53.CrossRef
Metadata
Title
Unusual manifestation of monoclonal gammopathy of undetermined significance: a false serum creatinine elevation
Authors
Yoshinosuke Shimamura
Takuto Maeda
Yayoi Ogawa
Yuki Nagai
Toshiya Shinohara
Hideki Takizawa
Publication date
01-05-2020
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 2/2020
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-019-00438-9

Other articles of this Issue 2/2020

CEN Case Reports 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.